Signal Genetics signalgenetics.com


Public lists: Genomics (520)

Signal Genetics (NASDAQ: SGNL) is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. Their MyPRS (Myeloma Prognostic Risk Signature) test is a microarray-based gene expression profiling (GEP) assay used to assist the management of patients with multiple myeloma (MM) and related disorders.

Signal Genetics (NASDAQ: SGNL) is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. Th...Show all

Company (IPO / Went public)

Phone: 760-537-4100

Fax:

5740 Fleet Street

Carlsbad, 92008
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Signal Genetics $8.5M Jun 18, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Signal Genetics Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
System and method for classification of patients Sep 30, 2010 Apr 07, 2015 Patent
System and method for classification of patients Nov 20, 2014 Application